| Financial Year |
March 31 2023 |
| Monetary Funds |
764,773,468.45 |
| Held-for-trading Financial Assets |
1,800,047,317.22 |
| Notes Receivable |
58,976,107.30 |
| Accounts Receivable |
1,056,487,172.78 |
| Advances to Suppliers |
46,905,315.14 |
| Other Receivables |
56,097,609.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
890,558,435.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
205,151,976.40 |
| Total Current Assets |
4,920,830,082.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
350,442,274.87 |
| Investment Properties |
46,492,529.04 |
| Fixed Assetes |
1,343,312,931.90 |
| Under-construction Projects |
289,879,190.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
178,208,624.90 |
| R&D expenses |
-- |
| Goodwill |
300,621,875.99 |
| Long-Term Deferred and Prepaid Expenses |
69,722,942.41 |
| Deferred Income Tax Assets |
93,533,014.05 |
| Other Non-Current Assets |
70,361,920.65 |
| Sub-Total of Non-Current Assets |
3,024,944,373.75 |
| Total Assets |
7,945,774,456.02 |
| Short-Term Loans |
191,899,656.28 |
| Trading Financial liabilities |
7,036,409.01 |
| Notes Payable |
25,282,033.92 |
| Accounts Payable |
713,708,362.71 |
| Accounts Received In Advance |
465,264.10 |
| Employee Compensation Payable |
70,141,149.82 |
| Taxes Payable |
50,277,107.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
181,768,166.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,721,407.08 |
| Other Current Liabilities |
61,931,693.61 |
| Sub-Total of Current Liabilities |
1,445,015,210.29 |
| Long-term Loans |
770,431,655.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
74,945,610.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
963,441,273.54 |
| Total Liabilities |
2,408,456,483.83 |
| Paid-In Capital(Or Share Stock) |
782,523,769.00 |
| Capital Surplus |
1,722,375,662.43 |
| Surplus Reserve |
392,607,920.77 |
| LESS:Treasury Stock |
268,164,908.66 |
| Undistributed Profits |
2,716,354,441.74 |
| Minority Stockholder's Interest |
189,720,553.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,347,597,418.21 |
| Owner's Equity（Stockholder's Equity） |
5,537,317,972.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,945,774,456.02 |
